LianBio ADR Ownership
LianBio ADR maintains a total of 108.06 Million outstanding shares. The majority of LianBio ADR outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LianBio ADR to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in LianBio ADR. Please pay attention to any change in the institutional holdings of LianBio ADR as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as LianBio ADR in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of LianBio ADR, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
LianBio |
LianBio Stock Ownership Analysis
About 79.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. LianBio ADR recorded a loss per share of 0.82. The entity last dividend was issued on the 15th of March 2024. LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey. Lianbio ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people. To find out more about LianBio ADR contact Yizhe Wang at 609 486 2308 or learn more at https://www.lianbio.com.LianBio ADR Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LianBio ADR insiders, such as employees or executives, is commonly permitted as long as it does not rely on LianBio ADR's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LianBio ADR insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ehong Gu over six months ago Disposition of 17889 shares by Ehong Gu of LianBio ADR at 0.32 subject to Rule 16b-3 | ||
Yu Debra over a year ago Acquisition by Yu Debra of 1000000 shares of LianBio ADR at 1.71 subject to Rule 16b-3 | ||
Adam Stone over a year ago Exercise or conversion by Adam Stone of 36300 shares of LianBio ADR subject to Rule 16b-3 | ||
Perceptive Advisors Llc over a year ago Exercise or conversion by Perceptive Advisors Llc of 36300 shares of LianBio ADR subject to Rule 16b-3 | ||
Chen Wei Wei over a year ago Acquisition by Chen Wei Wei of 36300 shares of LianBio ADR subject to Rule 16b-3 | ||
Perceptive Advisors Llc over a year ago LianBio ADR exotic insider transaction detected | ||
Perceptive Advisors Llc over a year ago Acquisition by Perceptive Advisors Llc of 36000 shares of LianBio ADR subject to Rule 16b-3 | ||
Brianne Jahn over a year ago Acquisition by Brianne Jahn of 224005 shares of LianBio ADR subject to Rule 16b-3 |
LianBio ADR Outstanding Bonds
LianBio ADR issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LianBio ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LianBio bonds can be classified according to their maturity, which is the date when LianBio ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Pair Trading with LianBio ADR
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LianBio ADR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LianBio ADR will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Noble Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Noble Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Noble Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Noble plc to buy it.
The correlation of Noble Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Noble Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Noble plc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Noble Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |